Literature DB >> 21479979

Protein Z is present in human breast cancer tissue.

Ewa Sierko1,2, Marek Z Wojtukiewicz3,4, Lech Zimnoch5, Piotr Tokajuk2, Walter Kisiel6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21479979     DOI： 10.1007/s12185-011-0846-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  9 in total

1.  Protein Z-dependent protease inhibitor (ZPI) is present in loco in human breast cancer tissue.

Authors:  Ewa Sierko; Marek Z Wojtukiewicz; Krystyna Ostrowska-Cichocka; Lech Zimnoch
Journal:  Thromb Haemost       Date:  2010-05-10       Impact factor: 5.249

2.  [Clinical significance of protein Z detection in patients with malignant tumors].

Authors:  Yi Shang; Xue-Yi Pan; Cai-Ping Ding; Xin-Mei Yang; Xiao-Yan Cai; Ying Ding; Rou-Ling Zhang
Journal:  Ai Zheng       Date:  2005-09

Review 3.  Pathways of coagulation/fibrinolysis activation in malignancy.

Authors:  L R Zacharski; M Z Wojtukiewicz; V Costantini; D L Ornstein; V A Memoli
Journal:  Semin Thromb Hemost       Date:  1992-01       Impact factor: 4.180

4.  Primary structure of vitamin K-dependent human protein Z.

Authors:  H Sejima; T Hayashi; Y Deyashiki; J Nishioka; K Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1990-09-14       Impact factor: 3.575

Review 5.  Protein Z-dependent regulation of coagulation.

Authors:  G J Broze
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

6.  Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor.

Authors:  A Tabatabai; R Fiehler; G J Broze
Journal:  Thromb Haemost       Date:  2001-04       Impact factor: 5.249

Review 7.  The role of hemostatic system inhibitors in malignancy.

Authors:  Marek Z Wojtukiewicz; Ewa Sierko; Walter Kisiel
Journal:  Semin Thromb Hemost       Date:  2007-10       Impact factor: 4.180

8.  Protein Z-dependent protease inhibitor binds to the C-terminal domain of protein Z.

Authors:  Alireza R Rezaie; Jong-Sup Bae; Chandrashekhara Manithody; Shabir H Qureshi; Likui Yang
Journal:  J Biol Chem       Date:  2008-05-23       Impact factor: 5.157

9.  Localisation of protein Z in vascular lesions of patients with atherosclerosis.

Authors:  J Greten; I Kreis; B Liliensiek; J Allenberg; J Amiral; R Ziegler; P P Nawroth
Journal:  Vasa       Date:  1998-08       Impact factor: 1.961
  9 in total
  4 in total

1.  PROZ May Serve as a Prognostic Biomarker for Early Hepatocellular Carcinoma.

Authors:  Xiaocong Jiang; Ting Song; Xiuhua Pan; Xinyu Zhang; Yuhong Lan; Li Bai
Journal:  Int J Gen Med       Date:  2021-08-06

2.  Protein Z/protein Z-dependent protease inhibitor system in loco in human gastric cancer.

Authors:  Ewa Sierko; Marek Z Wojtukiewicz; Lech Zimnoch; Piotr Tokajuk; Krystyna Ostrowska-Cichocka; Walter Kisiel
Journal:  Ann Hematol       Date:  2013-10-26       Impact factor: 3.673

3.  Novel risk models for early detection and screening of ovarian cancer.

Authors:  Matthew R Russell; Alfonsina D'Amato; Ciaren Graham; Emma J Crosbie; Aleksandra Gentry-Maharaj; Andy Ryan; Jatinderpal K Kalsi; Evangelia-Ourania Fourkala; Caroline Dive; Michael Walker; Anthony D Whetton; Usha Menon; Ian Jacobs; Robert L J Graham
Journal:  Oncotarget       Date:  2017-01-03

4.  Quantification of protein Z expression in lung adenocarcinoma tissues and cells.

Authors:  Hong Wang; Fang Huang; Xue-Yi Pan; Ze-Bin Guan; Wen-Bing Zeng; Ming-Jie Li; Rui-Hao Zhang
Journal:  Springerplus       Date:  2016-07-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.